Nordson Q2 FY2025 sales $683M (+5%), adj EPS $2.42 beats midpoint; Q3 guide $710-750M

NORDSON CORP

2025-Q2 EPS reported $3.62 vs consensus $2.41 ▲ beat (+50.4%)

Q2 sales $683M (+5% YoY) with 8% acquisition benefit offset by 2% organic decline.
Reported EPS $1.97 vs $2.05 prior year; adjusted EPS $2.42 (+3% YoY) above guidance midpoint.
Advanced Technology Solutions organic sales +18% YoY; Medical & Fluid Solutions +20% (incl. Atrion).
Q3 guidance: sales $710-$750M, adjusted EPS $2.55-$2.75 per diluted share.
Backlog grew ~5% sequentially; company repurchased $85M in shares during the quarter.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.